Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297

1.

Improving immunotherapy.

Crunkhorn S.

Nat Rev Drug Discov. 2020 Feb;19(2):92. doi: 10.1038/d41573-020-00010-6. No abstract available.

PMID:
32020076
2.

Hydrogel fights infection and inflammation.

Crunkhorn S.

Nat Rev Drug Discov. 2020 Feb;19(2):92. doi: 10.1038/d41573-020-00009-z. No abstract available.

PMID:
32020075
3.

Sorafenib analogue combats MRSA.

Crunkhorn S.

Nat Rev Drug Discov. 2020 Feb;19(2):92. doi: 10.1038/d41573-020-00008-0. No abstract available.

PMID:
32020074
4.

Restoring FGF21 reverses pancreatitis.

Crunkhorn S.

Nat Rev Drug Discov. 2020 Feb;19(2):89. doi: 10.1038/d41573-020-00004-4. No abstract available.

PMID:
32020069
5.

Lowering mutant huntingtin protein.

Crunkhorn S.

Nat Rev Drug Discov. 2020 Jan;19(1):22. doi: 10.1038/d41573-019-00207-4. No abstract available.

PMID:
31907428
6.

GPR146 inhibition protects against atherosclerosis.

Crunkhorn S.

Nat Rev Drug Discov. 2020 Jan;19(1):22. doi: 10.1038/d41573-019-00204-7. No abstract available.

PMID:
31907427
7.

Reversing resistance to MRSA.

Crunkhorn S.

Nat Rev Drug Discov. 2020 Jan;19(1):22. doi: 10.1038/d41573-019-00205-6. No abstract available.

PMID:
31907426
8.

Decoy receptor targets lung cancer.

Crunkhorn S.

Nat Rev Drug Discov. 2020 Jan;19(1):22. doi: 10.1038/d41573-019-00206-5. No abstract available.

PMID:
31907425
9.

Phages fight alcoholic hepatitis.

Crunkhorn S.

Nat Rev Drug Discov. 2020 Jan;19(1):20. doi: 10.1038/d41573-019-00198-2. No abstract available.

PMID:
31907420
10.

Expanding the gene editing landscape.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Nov;18(12):904. doi: 10.1038/d41573-019-00178-6. No abstract available.

PMID:
31780843
11.

Overcoming adaptive resistance in AML.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Oct;18(11):826. doi: 10.1038/d41573-019-00172-y. No abstract available.

PMID:
31673134
12.

Deep learning identifies DDR1 kinase inhibitors.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Oct;18(11):826. doi: 10.1038/d41573-019-00170-0. No abstract available.

PMID:
31673133
13.

Towards long-acting HIV inhibitors.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Oct;18(11):826. doi: 10.1038/d41573-019-00169-7. No abstract available.

PMID:
31673132
14.

Eliminating vaccine cross-reactivity.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Oct;18(11):826. doi: 10.1038/d41573-019-00171-z. No abstract available.

PMID:
31673131
15.

CAR-T cells combat cardiac fibrosis.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Oct;18(11):823. doi: 10.1038/d41573-019-00162-0. No abstract available.

PMID:
31673127
16.

DuoCAR-T cells eliminate HIV.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Sep;18(10):748. doi: 10.1038/d41573-019-00150-4. No abstract available.

PMID:
31570845
17.

Profiling the malaria transcriptome.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Sep;18(10):748. doi: 10.1038/d41573-019-00151-3. No abstract available.

PMID:
31570844
18.

Targeting NETs to treat gallstones.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Sep;18(10):748. doi: 10.1038/d41573-019-00148-y. No abstract available.

PMID:
31570843
19.

Orphan GPCR exhibits anti-opioid activity.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Sep;18(10):748. doi: 10.1038/d41573-019-00149-x. No abstract available.

PMID:
31570842
20.

Reversing Rett syndrome.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Sep;18(10):748. doi: 10.1038/d41573-019-00143-3. No abstract available.

PMID:
31570839
21.

CAR T cells combat cardiac fibrosis.

Crunkhorn S.

Nat Rev Cardiol. 2019 Dec;16(12):699. doi: 10.1038/s41569-019-0287-x. No abstract available.

PMID:
31554926
22.

CAR T cells combat cardiac fibrosis.

Crunkhorn S.

Nat Rev Immunol. 2019 Nov;19(11):659. doi: 10.1038/s41577-019-0226-4. No abstract available.

PMID:
31551571
23.

Programming bacteria to fight cancer.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Sep;18(9):668. doi: 10.1038/d41573-019-00137-1. No abstract available.

PMID:
31477866
24.

Role of the gut microbiota in PCOS.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Sep;18(9):668. doi: 10.1038/d41573-019-00138-0. No abstract available.

PMID:
31477865
25.

Enhancing CAR-T cell activity.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Sep;18(9):668. doi: 10.1038/d41573-019-00135-3. No abstract available.

PMID:
31477864
26.

Applying the human metabolome.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Sep;18(9):668. doi: 10.1038/d41573-019-00136-2. No abstract available.

PMID:
31477863
27.

Expanding the RNA-editing toolbox.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Sep;18(9):667. doi: 10.1038/d41573-019-00128-2. No abstract available.

PMID:
31477858
28.

Body-on-a-chip for anticancer drug testing.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jul;18(8):584. doi: 10.1038/d41573-019-00111-x. No abstract available.

PMID:
31367053
29.

Overcoming chemoresistance.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jul;18(8):584. doi: 10.1038/d41573-019-00109-5. No abstract available.

PMID:
31367052
30.

Epigenetic mechanism of systemic sclerosis.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jul;18(8):584. doi: 10.1038/d41573-019-00112-w. No abstract available.

PMID:
31367051
31.

Blocking hyaluronan synthesis.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jul;18(8):584. doi: 10.1038/d41573-019-00110-y. No abstract available.

PMID:
31367050
32.

Prospecting for new antibiotics.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jul;18(8):581. doi: 10.1038/d41573-019-00108-6. No abstract available.

PMID:
31367049
33.

Phage therapy for Mycobacterium abscessus.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jul;18(7):500. doi: 10.1038/d41573-019-00097-6. No abstract available.

PMID:
31267076
34.

Controlling CRISPR-Cas9 activity.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jul;18(7):500. doi: 10.1038/d41573-019-00094-9. No abstract available.

PMID:
31267075
35.

Towards a vaccine for equine encephalitis viruses.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jul;18(7):500. doi: 10.1038/d41573-019-00095-8. No abstract available.

PMID:
31267073
36.

Inhibiting insulin degradation.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jul;18(7):500. doi: 10.1038/d41573-019-00096-7. No abstract available.

PMID:
31267072
37.

Inhibiting sebum production to treat acne.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jul;18(7):498. doi: 10.1038/d41573-019-00092-x. No abstract available.

PMID:
31267070
38.

Selectively targeting antibiotic-resistant bacteria.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jun;18(6):420. doi: 10.1038/d41573-019-00080-1. No abstract available.

PMID:
31160771
39.

Reversing obesity and diabetes.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jun;18(6):420. doi: 10.1038/d41573-019-00082-z. No abstract available.

PMID:
31160770
40.

Targeting the epitranscriptome in AML.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jun;18(6):420. doi: 10.1038/d41573-019-00079-8. No abstract available.

PMID:
31160769
41.

Improving safety and efficacy of immunotherapeutics.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jun;18(6):420. doi: 10.1038/d41573-019-00081-0. No abstract available.

PMID:
31160768
42.

Epigenetic route to recovery for spinal cord injury.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Jun;18(6):420. doi: 10.1038/d41573-019-00073-0. No abstract available.

PMID:
31160766
43.

Inhibiting Wolbachia to treat parasitic diseases.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Apr 5. doi: 10.1038/d41573-019-00058-z. [Epub ahead of print] No abstract available.

PMID:
31048806
44.

Targeting EBV-associated malignancies.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Apr 5. doi: 10.1038/d41573-019-00057-0. [Epub ahead of print] No abstract available.

PMID:
31048805
45.

Targeting macrophages enhances chemotherapy.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Apr 5. doi: 10.1038/d41573-019-00059-y. [Epub ahead of print] No abstract available.

PMID:
31048804
46.

Antifungal agent fights cystic fibrosis.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Apr 5. doi: 10.1038/d41573-019-00056-1. [Epub ahead of print] No abstract available.

PMID:
31048803
47.

Targeting cancer cell metabolism in glioblastoma.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Mar 27. doi: 10.1038/d41573-019-00054-3. [Epub ahead of print] No abstract available.

PMID:
31048798
48.

Targeting cancer cell metabolism in glioblastoma.

Crunkhorn S.

Nat Rev Cancer. 2019 May;19(5):250. doi: 10.1038/s41568-019-0139-3. No abstract available.

PMID:
30944412
49.

Sleep protects against atherosclerosis.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Mar 12. doi: 10.1038/d41573-019-00041-8. [Epub ahead of print] No abstract available.

PMID:
30936520
50.

Reprogrammed α-cells reverse diabetes.

Crunkhorn S.

Nat Rev Drug Discov. 2019 Mar 12. doi: 10.1038/d41573-019-00039-2. [Epub ahead of print] No abstract available.

PMID:
30936519

Supplemental Content

Loading ...
Support Center